OCT 28, 2015 2:20 PM PDT

Toll-Like Receptor Agonists Boost the Power of Vaccines

WRITTEN BY: Kara Marker
Flu season looms overhead, and it's more important than ever to get vaccinated. Every year the flu virus mutates, and scientists make complicated predictions in order to make an effective vaccine. Getting a flu vaccine does more than decrease your risk of contracting full-blown flu - fever, body aches, sore throat, coughing - the whole nine yards. Getting vaccinated also protects people who are immunocompromised and can't get the vaccine - babies, the elderly, and people with autoimmune diseases. 
A toll-like receptor
New research shows potential for vaccines to become even more effective, using toll-like receptor (TLR) agonists (activators) to get a stronger response from the immune system. The study, published in ACS Central Science, investigated the TLR agonist mechanism of directing the immune system, used to boost the effectiveness of antigen-based vaccines. Some vaccines, like the annual flu vaccine, recruit a dead or weakened virus to stimulate the innate immune system and activate TLRs. Antigen-based vaccines use only a small fragment of the virus to stimulate the immune system, and subsequently they achieve a smaller immune response - however with less side effects than whole pathogen vaccines.

TLRs are "first-responders" that play a large role in detecting infecting pathogens through pattern recognition, a process where both the innate and adaptive immune systems are activated to fight the infection (Nature). TLR activators are "common adjuvants" added to antigen-based vaccines in order to enhance their effectiveness. Dr. Aaron Esser-Kahn, lead researcher of the study, and his team looked to manipulate this mechanism to improve vaccines using the molecules TLR agonists use to activate the immune system. 

Significant findings showed TLR agonist activity is impacted by their arrangment in space. Esser-Kahn and his team then looked to "probe this biological machinery" by displaying three different TLR agonists "with a defined spatial orientation" on synthesized probes. Rather than simply combining the three TLR agonists together to stimulate an immune response, the probe that spatially connected the activators raised a more effective immune response.

Moving forward, Esser-Kahn and his team will continue by breaking down the TLR agonists to see which specific actions each component performs and which actions are most important to activating an immune response. 

Watch the following TLR animation to visualize how these "cellular watchmen" naturally stimulate the innate immune system during infection. 



Source: ScienceDaily

 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 28, 2020
Neuroscience
JAN 28, 2020
Gut Bacteria Influences Behavior in Young Children
Research now suggests that the presence of different gut bacteria may significantly impact children’s behavior, causing some to act out, and some to...
FEB 02, 2020
Cell & Molecular Biology
FEB 02, 2020
New T Cell Therapy is a Universal Approach to Target Cancer
For years, researchers have been trying to harness the power of the assassins of the immune system - killer T cells....
FEB 04, 2020
Microbiology
FEB 04, 2020
Revealing How a Common Virus Evades the Immune System
The human metapneumovirus (HMPV) might now be well-known, but it is the second biggest cause of respiratory infections....
FEB 03, 2020
Neuroscience
FEB 03, 2020
Genetic Characterization of Bipolar Disorders, Major Depressive Disorder
Mood disorders, like Bipolar, Major Depressive Disorder, and Schizophrenia, among others, are difficult to define clinically.  Unlike disorders that a...
FEB 16, 2020
Microbiology
FEB 16, 2020
Images of Coronavirus Are Released as First Death Outside China is Reported
Previously known as 2019-nCoV, the virus has a new name: SARS-CoV-2, which is the cause of what's being called COVID-19 disease....
FEB 25, 2020
Cannabis Sciences
FEB 25, 2020
State to State: Reciprocity for Marijuana Cards Proves Challenging
When a person receives a medical marijuana card, are they good to go, anywhere in the U.S.? No -- it turns out, it can be hard to access medical cannabis o...
Loading Comments...